BEDFORD, Mass., Jan. 13 /PRNewswire/ -- Toxikon, a successful, 30-year old preclinical research organization with highly diversified capabilities headquartered in the Greater Boston area, announces that Joseph Pav, Ph.D. has joined the firm to direct the continued growth of the preclinical and clinical bioanalytical services unit. Dr. Pav brings a wealth of knowledge and experience to the organization from his prior roles in method development, validation, analysis, and automation. His prior experience included senior scientific and management roles at Purdue Frederick, Boehringer Ingelheim, Wyeth Research, and PPDI.
CONTACT: Joann Hoxha of Toxikon Corporation, +800-458-4141, ext. 132,
Web site: http://www.toxikon.com/